Target intelligence / Profile preview

Small nucleolar RNA SNORD99 (SNORD99)

Target
SNORD99
Molecular classification
Non-coding RNA, Small nucleolar RNA (snoRNA), C/D box snoRNA
01

Overview

Small nucleolar RNA SNORD99 is a non-coding RNA in the C/D box class of snoRNAs, primarily located in the nucleolus of eukaryotic cells[5]. These molecules function as guide RNAs, enabling site-specific 2'-O-methylation of other RNAs, particularly ribosomal RNA (28S rRNA at residue A2774)[5]. SNORD99 is primarily involved in the post-transcriptional modification of rRNA and snRNA, contributing to ribosome biogenesis and function[1][4][5]. Recent studies indicate an emerging role in cancer: SNORD99 is upregulated in endometrial cancer, where it enhances cell proliferation and migration by guiding methylation of genes involved in programmed cell death (pyroptosis), such as GSDMD, and potentially influencing cancer development[3]. SNORD99 (HBII-420) expression patterns have also been suggested as useful for tumor subtyping[2][3]. There are no established drug interactions or known safety concerns related to therapeutic targeting, and SNORD99 is not currently considered a direct therapeutic target (such as a receptor or enzyme), but it serves as a useful biomarker in research contexts.

Other names
HBII-420small nucleolar RNA, C/D box 99SNORD99
02

Biological functions

Guide RNA for site-specific 2'-O-methylation of RNABiogenesis and modification of small nuclear RNA (snRNA)Biogenesis and modification of ribosomal RNA (rRNA)Regulation of gene expression (emerging evidence)
03

Disease associations

Cancer (especially implicated in endometrial cancer and some data on lung adenocarcinoma and multiple myeloma)Other (role in tumor subtyping across multiple cancers)
04

Biomarkers

Elevated expression as a potential biomarker for endometrial cancer and subtyping other cancers

Beyond the preview

Go deeper on Small nucleolar RNA SNORD99 (SNORD99).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small nucleolar RNA SNORD99 (SNORD99).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call